Naproxen Sodium
- Product NDC
- 55910-851
- 11-digit product format
- 559100851
- Labeler code
- 55910
- Product ID
- 55910-851_2b32b79e-1f44-4da7-b767-40567edbdad8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
- Application
- ANDA202807
- Marketing category
- ANDA
- Marketing start
- 2022-01-03
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55910-851-20 | 55910085120 | 1 BOTTLE, PLASTIC in 1 BOX (55910-851-20) > 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC | 2022-01-03 | 0000-00-00 | No | No | Current |
| 55910-851-40 | 55910085140 | 1 BOTTLE, PLASTIC in 1 BOX (55910-851-40) > 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC | 2022-01-03 | 0000-00-00 | No | No | Current |